[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100573247":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":11,"centralContacts":27,"locations":33,"responsibleParty":50,"collaborators":11,"id":52,"slug":11,"hasResults":53,"nctId":54,"briefTitle":55,"officialTitle":56,"acronym":11,"eligibilityCriteria":57,"healthyVolunteers":53,"sex":58,"minAge":59,"maxAge":60,"enrollmentInfo":61,"targetDuration":11,"studyType":64,"phases":65,"briefSummary":67,"conditions":68,"keywords":11,"overallStatus":36,"whyStopped":11,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":74,"completionDateStruct":76,"leadSponsor":78,"locationsCount":79},{"fullName":5,"class":6},"The Second Affiliated Hospital of Chongqing Medical University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Coenzyme Q10","EXPERIMENTAL",null,[13],"Drug: Coenzyme Q10",{"label":15,"type":16,"description":11,"interventionNames":17},"Placebo","PLACEBO_COMPARATOR",[18],"Other: Placebo",[20,24],{"type":21,"name":9,"description":22,"armGroupLabels":23,"otherNames":11},"DRUG","Coenzyme Q10 was administered from admission to one month after discharge at a dose of 200 mg per day (200 mg\u002Fqd).",[9],{"type":6,"name":15,"description":25,"armGroupLabels":26,"otherNames":11},"The placebo was administered from hospital admission until one month after discharge.",[15],[28],{"name":29,"role":30,"phone":31,"phoneExt":11,"email":32},"Guangyou Duan, ph.D","CONTACT","(+86)18323376014","duangy@hospital.cqmu.edu.cn",[34],{"facility":35,"status":36,"city":37,"state":38,"zip":39,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"Guangyou Duan","RECRUITING","Chongqing","Chongqing Municipality","400010","China","CN",{"type":43,"coordinates":44},"Point",[45,46],106.55771,29.56026,{"lat":46,"lon":45},[49],{"name":35,"role":30,"phone":31,"phoneExt":11,"email":32},{"type":51,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100573247",false,"NCT06743802","The Effect of Coenzyme Q10 in Preventing Pain After Thoracoscopic Surgery","The Effect of Coenzyme Q10 in Preventing Pain After Thoracoscopic Surgery: a Randomized Controlled Trial","Inclusion Criteria:\n\n* Aged 18-75 years;\n* American Society of Anesthesiology (ASA) physical status classification I-III;\n* Scheduled for elective lung resection surgery under thoracoscopy;\n* Voluntarily opting for patient-controlled intravenous analgesia;\n* Willing to participate in this trial after consultation with the patient or their family and signing the informed consent form.\n\nExclusion Criteria:\n\n* History of previous thoracotomy or thoracoscopic surgery;\n* Patients converted to open thoracotomy intraoperatively;\n* Severe hepatic or renal dysfunction;\n* History of substance abuse;\n* Pregnancy or breastfeeding;\n* History of chronic pain;\n* Use of coenzyme Q10 for more than one month;\n* Allergy to coenzyme Q10;\n* Patients unable to communicate or cooperate.","ALL","18 Years","75 Years",{"count":62,"type":63},264,"ESTIMATED","INTERVENTIONAL",[66],"PHASE4","This study aimed to assess the effectiveness of Coenzyme Q10 in preventing both acute and chronic pain following thoracoscopic surgery, with a focus on its potential benefits in reducing the incidence and severity of pain.",[69],"Postoperative Pain","2025-02-25",{"date":72,"type":73},"2025-02-26","ACTUAL",{"date":75,"type":73},"2025-01-09",{"date":77,"type":63},"2026-03-20",{"name":5,"class":6},1]